Klener, P., Fronkova, E., Kalinova, M., Belada, D., Forsterova, K., Pytlik, R., Blahovcova, P., Simkovic, M., Salek, D., Mocikova, H., Prochazka, V., Janikova, A., Vaskova, M., Mejstrikova, E., Kodet, R., Trka, J., & Trneny, M. (2018). potential loss of prognostic significance of minimal residual disease assessment after R‐CHOP‐based induction in elderly patients with mantle cell lymphoma in the era of rituximab maintenance. Hematological oncology, 36(5), 773–778. http://access.bl.uk/ark:/81055/vdc_100075218826.0x000046